European Diabetes Summit 2026
The European Diabetes Summit – 2026, under the theme "Uniting Knowledge For Better Diabetes Care", is strategically designed to explore the most current, evidence-based, and clinically impactful developments in endocrinology and diabetology. The congress will provide a dynamic platform for deep scientific engagement, clinical insight, and translational innovation.
1. Emerging Therapies in Diabetes Management Explore novel pharmacologic agents including dual and triple agonists (e.g., GLP-1/GIP receptor co agonists), small-molecule insulin sensitizers, and oral semaglutide. Delve into personalized insulin therapy, beta-cell preservation strategies, and immune modulation in type 1 diabetes.
2. Precision Endocrinology and Genomic Medicine Understand how genomics, epigenetics, and single-cell sequencing are redefining endocrine disease classification and enabling precision diagnosis and individualized therapy for thyroid disorders, adrenal pathologies, and genetic syndromes.
3. Diabetes Technology and Digital Health Examine the clinical integration of advanced diabetes technologies such as automated insulin delivery systems (AID), continuous glucose monitoring (CGM), wearable biosensors, mobile health applications, and artificial intelligence for clinical decision support.
4. Cardio-Renal-Metabolic Interventions Review the evolving role of SGLT2 inhibitors and GLP-1 receptor agonists in reducing cardiovascular events and renal progression in people with type 2 diabetes, as well as new agents targeting metabolic inflammation and lipotoxicity.
5. Endocrine-Oncology and Rare Hormonal Disorders Explore innovations in the management of endocrine malignancies (thyroid cancer, adrenal tumors, pituitary adenomas), paraneoplastic syndromes, and rare genetic endocrine syndromes through a combination of molecular diagnostics and targeted therapies. UNITING KNOWLEDGE FOR BETTER DIABETES CARE
6. Translational and Experimental Endocrinology Gain insight into bench-to-bedside research, including stem-cell derived islet transplantation, gene therapy for monogenic diabetes, and advances in endocrine disruptor science.
7. Global Health, Health Equity & Chronic Disease Prevention Discuss the social and structural determinants of diabetes care, innovations in low-resource settings, and large-scale prevention programs addressing obesity, lifestyle, and environmental risks